Newsletter - Alzheimer Europe September 2020 newsletter https://alzheimereurope.newsweaver.com/Newsletter/ en-us 01 Oct 2020 02:30:06 CEST 01 Oct 2020 02:30:06 CEST https://alzheimereurope.newsweaver.com/Newsletter/rss.xml Newsweaver info@alzheimer-europe.org () support@newsweaver.ie (Newsweaver) 60 true Welcome https://alzheimereurope.newsweaver.com/Newsletter/ud68wxoc7pz?lang=en?rss=true Alzheimer Europe’s September 2020 [ https://alzheimereurope.newsweaver.com/Newsletter/1qjtgt0zlzb/external ] newsletter [ https://alzheimereurope.newsweaver.com/Newsletter/1qjtgt0zlzb/external ] [ https://alzheimereurope.newsweaver.com/Newsletter/1qjtgt0zlzb/external ] brings you the latest news on developments in the dementia field, across Europe and beyond. Summaries of a few of our top stories appear below. Our monthly newsletter reaches around 11,000 people and we are always happy to receive feedback, or suggestions regarding news items to share in future issues. Click here to download full newsletter [ https://alzheimereurope.newsweaver.com/Newsletter/1qjtgt0zlzb/external ] [ https://alzheimereurope.newsweaver.com/Newsletter/1qjtgt0zlzb/external ] 01 Oct 2020 12:00:00 CEST 7b800cb700ea3a12565f95749a886d70 Feature Article <p style="text-align: justify;"><img align="left" src="http://alzheimereurope.newsweaver.com/v2files/shard1/56305/2b/92a8976269fb1f449eddd2.jpg" style="margin: 5px;" width="150" height="100" hspace="5" vspace="5" alt="" />Alzheimer Europe’s <a href="https://alzheimereurope.newsweaver.com/Newsletter/1qjtgt0zlzb/external" target="_blank" rel="noopener"><strong>September 2020</strong> <strong>newsletter</strong></a> brings you the latest news on developments in the dementia field, across Europe and beyond.</p> <p style="text-align: justify;">Summaries of a few of our top stories appear below.</p> <p style="text-align: justify;">Our monthly newsletter reaches around 11,000 people and we are always happy to receive feedback, or suggestions regarding news items to share in future issues.</p> <p style="text-align: justify;"><a href="https://alzheimereurope.newsweaver.com/Newsletter/1qjtgt0zlzb/external" target="_blank" rel="noopener"><strong>Click here to download full newsletter</strong></a></p> <p> </p> 8 Sep: EU4Health Civil Society Alliance publishes position paper https://alzheimereurope.newsweaver.com/Newsletter/1m9guluodxw?lang=en?rss=true Ahead of debates in the European Parliament on EU4Health, the EU’s forthcoming standalone health programme, the EU4Health Civil Society Alliance has published a position statement outlining key principles and points which must underpin the future Health Programme. 01 Oct 2020 12:00:00 CEST 9c5ed2d2b1024f24dd0774624ca0bdb8 Other Articles <p style="text-align: justify;"><img align="left" src="http://alzheimereurope.newsweaver.com/v2files/shard1/56305/55/d9a4820a11646b7081f21a.png" style="margin: 0px;" width="120" height="67" hspace="0" vspace="0" alt="" />Ahead of debates in the European Parliament on EU4Health, the EU’s forthcoming standalone health programme, the EU4Health Civil Society Alliance has published a position statement outlining key principles and points which must underpin the future Health Programme.</p> <p style="text-align: justify;"> </p> https://www.alzheimer-europe.org/News/EU-developments/Tuesday-08-September-2020-EU4Health-Civil-Society-Alliance-publishes-position-paper-on-EU-Health-Programme 15 Sep: MEPs in EAA are making dementia a priority https://alzheimereurope.newsweaver.com/Newsletter/167kbpiwraa?lang=en?rss=true Two Vice-chairs of the European Alzheimer’s Alliance (EAA), submitted written questions to the Commission this month. They asked about the place of dementia in the forthcoming European Disability Strategy, and in the future research priorities of the EU. The EAA has also gained a new member, Chrysoula Zacharopoulou MEP. 01 Oct 2020 12:00:00 CEST 4086895dc42c8f4fd4c85b89c8485e98 Other Articles <p style="text-align: justify;"><img align="left" src="http://alzheimereurope.newsweaver.com/v2files/shard1/56305/94/f547401b583a31fac1d4e3.jpg" style="margin: 5px;" width="150" height="50" hspace="5" vspace="5" alt="" />Two Vice-chairs of the European Alzheimer’s Alliance (EAA), submitted written questions to the Commission this month. They asked about the place of dementia in the forthcoming European Disability Strategy, and in the future research priorities of the EU. The EAA has also gained a new member, Chrysoula Zacharopoulou MEP.</p> https://www.alzheimer-europe.org/News/European-Alzheimer-s-Alliance 21 Sep: World Alzheimer’s Day activities adapted due to COVID https://alzheimereurope.newsweaver.com/Newsletter/1csbah28ulr?lang=en?rss=true Congratulations to our members for all their hard work this World Alzheimer’s Day. The pandemic has put up so many roadblocks, but our members found new and creative ways to carry out their all-important awareness-raising and fundraising activities. Just one example is the "Memory Stay" organised by Association Luxembourg Alzheimer. 01 Oct 2020 12:00:00 CEST 04b4866e06076a1f600d9dacfaf6771b Other Articles <p style="text-align: justify;"><img align="left" src="http://alzheimereurope.newsweaver.com/v2files/shard1/56305/84/69de65a8562e86ed5975d5.jpg" style="margin: 5px;" width="100" height="100" hspace="5" vspace="5" alt="" />Congratulations to our members for all their hard work this World Alzheimer’s Day. The pandemic has put up so many roadblocks, but our members found new and creative ways to carry out their all-important awareness-raising and fundraising activities.</p> <p style="text-align: justify;">Just one example is the "Memory Stay" organised by Association Luxembourg Alzheimer.</p> <p style="text-align: justify;"> </p> <p style="text-align: justify;"> </p> https://www.alzheimer-europe.org/News/Members-news/Monday-21-September-2020-Association-Luxembourg-Alzheimer-hosts-Memory-Stay 23 Sep: Phase II semorinemab trial did not meet main endpoint https://alzheimereurope.newsweaver.com/Newsletter/1mtiw8odm59?lang=en?rss=true On 23 September, the Swiss-based biopharmaceutical company AC Immune announced that its partner Genentech, a member of the Roche group, has reported top line results from a Phase II clinical trial of semorinemab, an anti-tau monoclonal antibody, in early Alzheimer’s disease (AD). Unfortunately the results show that the study did not meet its primary efficacy endpoint. 01 Oct 2020 12:00:00 CEST 22685d0c34905e43fcc2921d8a206b82 Other Articles <p style="text-align: justify;"><img align="left" src="http://alzheimereurope.newsweaver.com/v2files/shard1/56305/04/520a0860ca59e5df55b3c9.jpg" style="margin: 5px;" width="150" height="76" hspace="5" vspace="5" alt="" />On 23 September, the Swiss-based biopharmaceutical company AC Immune announced that its partner Genentech, a member of the Roche group, has reported top line results from a Phase II clinical trial of semorinemab, an anti-tau monoclonal antibody, in early Alzheimer’s disease (AD). Unfortunately the results show that the study did not meet its primary efficacy endpoint.</p> <p style="text-align: justify;"> </p> https://www.alzheimer-europe.org/News/Science-watch/Wednesday-23-September-2020-The-TAURIEL-Phase-II-study-evaluating-semorinemab-in-early-AD-did-not-meet-its-primary-efficacy-endpoint 29 Sep: Register now for our virtual conference #30AEC! https://alzheimereurope.newsweaver.com/Newsletter/1or04gyxbv5?lang=en?rss=true The 30th Alzheimer Europe Conference (#30AEC) is fast-approaching, with only three weeks to go! The conference will take place online for the first time, from 20-22 October, and registrations will close on 19 October. Conference registration gives you admission to all sessions, access to poster presentations, to chat rooms and to all conference videos after the event. 01 Oct 2020 12:00:00 CEST 0c0eecd987e671c6c1c4f4f02c7e1814 Other Articles <p style="text-align: justify;"><img align="left" src="http://alzheimereurope.newsweaver.com/v2files/shard1/56305/dc/2c87528a58489c9eef617f.jpg" style="margin: 5px;" width="150" height="100" hspace="5" vspace="5" alt="" />The 30<sup>th</sup> Alzheimer Europe Conference (#30AEC) is fast-approaching, with only three weeks to go! The conference will take place online for the first time, from 20-22 October, and registrations will close on 19 October. Conference registration gives you admission to all sessions, access to poster presentations, to chat rooms and to all conference videos after the event.</p> <p style="text-align: justify;"> </p> <p style="text-align: justify;"> </p> https://www.alzheimer-europe.org/News/Alzheimer-Europe/Tuesday-29-September-2020-The-30th-Alzheimer-Europe-Conference-is-nearly-here-register-now